Trajan Group Holdings
Trajan Group Holdings develops and manufactures analytical and life sciences instruments and devices. The company focuses on creating solutions for biological, environmental, and food-related measurements, aiming to improve personal health through scientific tools. Trajan partners in producing critical components and materials for analytical workflow and measurement.
Short position
Trajan Group Holdings (ASX:TRJ) has 0.00% of its shares on issue reported as short positions as of 17 July 2026, or about 1,406 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. TRJ is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Trajan Group Holdings (TRJ) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $161.4Mvs $166.5M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −$623.0Kvs −$4.5M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −$0.004vs −$0.029 (FY25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- −3.1%FY
- EPS YoY
- n/aTTM
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 38.4%
- Operating margin
- 1.9%
- Net margin
- −0.4%
- FCF margin
- −2.0%
- ROE
- −0.6%
- ROA
- −0.3%
- FCF conversion
- n/a
- Net debt (excl. leases)
- $34.6M
- Net debt / EBITDA
- 3.8×
- Current ratio
- 2.1×
- Interest cover
- 0.9×
- Cash dividends paid / net profit
- n/a
- Market cap
- $43.6M
- P/E
- n/a
- P/B
- 0.4×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $161.4M | $166.5M | $155.0M | $162.2M |
| Gross profit | $62.0M | $63.5M | $62.6M | $67.1M |
| Operating income | $3.0M | $3.5M | $281.0K | $9.4M |
| EBITDA | $9.0M | $8.1M | −$20.9M | $14.2M |
| EBIT | $2.7M | $1.8M | −$27.1M | $8.8M |
| Interest expense | $3.4M | $3.5M | $4.0M | $3.3M |
| Pretax income | −$711.0K | −$1.7M | −$31.1M | $5.5M |
| Tax | −$88.0K | $2.7M | −$5.8M | $3.6M |
| NPAT | −$623.0K | −$4.5M | −$25.3M | $1.9M |
| Net interest income | −$4.2M | −$4.3M | −$4.7M | −$4.0M |
| EPS basic | −$0.004 | −$0.029 | −$0.17 | $0.012 |
| EPS diluted | −$0.004 | −$0.029 | −$0.17 | $0.012 |
| Shares | 152.9M | 152.4M | 152.2M | 152.1M |
Financial reports
The company's own filings, newest first
- FY26 Appendix 4E and Annual ReportAnnual Results27 Aug 2026via asx_announcements
- FY26 Financial Results PresentationFinancial Report27 Aug 2026via asx_announcements
- FY26 Financial Results ReleaseFinancial Report27 Aug 2026via asx_announcements
- TRJ FY26 Full Year Results and Investor Webcast NotificationFull Year Results13 Aug 2026via asx_announcements
- H1 FY26 Appendix 4D and Interim ReportHalf Year Results26 Feb 2026via asx_announcements
- H1 FY26 Financial Results ReleaseFinancial Report26 Feb 2026via asx_announcements
- H1 FY26 Financial Results PresentationFinancial Report26 Feb 2026via asx_announcements
- FY26 Half Year Results and Investor Webcast NotificationHalf Year Results29 Jan 2026via asx_announcements
- FY25 Financial Results ReleaseFinancial Report28 Aug 2025via asx_announcements
- FY25 Appendix 4E and Annual ReportAnnual Results28 Aug 2025via asx_announcements
Showing 10 of 24 reports